Madrigal Pharmaceuticals Inc. monthly returns
Madrigal Pharmaceuticals Inc. has averaged 3.65% a month with dividends reinvested, and risen in 47% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.
Month by month#
Data provided bySource: Twelve Data| Month | Path | Total return |
|---|---|---|
| Nov 2026 | -1.9% | |
| Oct 2026 | -14.6% | |
| Sep 2026 | -6.7% | |
| Aug 2026 | +15.6% | |
| Jul 2026 | -13.0% | |
| Jun 2026 | +8.0% | |
| May 2026 | -3.9% | |
| Apr 2026 | -1.2% | |
| Mar 2026 | +21.2% | |
| Feb 2026 | -11.7% | |
| Jan 2026 | -16.0% | |
| Dec 2025 | -2.5% | |
| Nov 2025 | +42.5% | |
| Oct 2025 | -8.7% | |
| Sep 2025 | +4.8% | |
| Aug 2025 | +44.7% | |
| Jul 2025 | -0.0% | |
| Jun 2025 | +9.9% | |
| May 2025 | -17.6% | |
| Apr 2025 | +0.8% | |
| Mar 2025 | -2.9% | |
| Feb 2025 | +1.9% | |
| Jan 2025 | +8.5% | |
| Dec 2024 | -6.0% | |
| Nov 2024 | +26.5% | |
| Oct 2024 | +22.2% | |
| Sep 2024 | -14.1% | |
| Aug 2024 | -13.2% | |
| Jul 2024 | +1.6% | |
| Jun 2024 | +18.6% | |
| May 2024 | +15.8% | |
| Apr 2024 | -23.6% | |
| Mar 2024 | +13.1% | |
| Feb 2024 | +9.0% | |
| Jan 2024 | -6.3% | |
| Dec 2023 | +13.8% | |
| Nov 2023 | +54.7% | |
| Oct 2023 | -10.0% | |
| Sep 2023 | -18.9% | |
| Aug 2023 | -12.3% | |
| Jul 2023 | -11.1% | |
| Jun 2023 | -17.0% | |
| May 2023 | -10.8% | |
| Apr 2023 | +28.8% | |
| Mar 2023 | -10.6% | |
| Feb 2023 | -6.0% | |
| Jan 2023 | -0.7% | |
| Dec 2022 | +314.0% | |
| Nov 2022 | -1.0% | |
| Oct 2022 | +9.0% | |
| Sep 2022 | -9.9% | |
| Aug 2022 | +14.8% | |
| Jul 2022 | -12.2% | |
| Jun 2022 | +7.8% | |
| May 2022 | -5.2% | |
| Apr 2022 | -28.7% | |
| Mar 2022 | +5.7% | |
| Feb 2022 | +61.3% | |
| Jan 2022 | -32.1% | |
| Dec 2021 | +2.5% | |
| Nov 2021 | +6.4% | |
| Oct 2021 | -2.6% | |
| Sep 2021 | -3.6% | |
| Aug 2021 | -5.2% | |
| Jul 2021 | -10.4% | |
| Jun 2021 | -13.3% | |
| May 2021 | -17.5% | |
| Apr 2021 | +16.4% | |
| Mar 2021 | -3.5% | |
| Feb 2021 | +2.0% | |
| Jan 2021 | +6.8% | |
| Dec 2020 | -4.8% | |
| Nov 2020 | -8.2% | |
| Oct 2020 | +7.2% | |
| Sep 2020 | +10.2% | |
| Aug 2020 | +5.0% | |
| Jul 2020 | -9.4% | |
| Jun 2020 | -2.4% | |
| May 2020 | +38.6% | |
| Apr 2020 | +25.3% | |
| Mar 2020 | -22.5% | |
| Feb 2020 | +3.8% | |
| Jan 2020 | -8.9% | |
| Dec 2019 | -17.7% | |
| Nov 2019 | +19.8% | |
| Oct 2019 | +7.2% | |
| Sep 2019 | -7.0% | |
| Aug 2019 | +6.2% | |
| Jul 2019 | -16.7% | |
| Jun 2019 | +13.4% | |
| May 2019 | -12.9% | |
| Apr 2019 | -15.3% | |
| Mar 2019 | -4.6% | |
| Feb 2019 | +13.4% | |
| Jan 2019 | +2.7% | |
| Dec 2018 | -2.5% | |
| Nov 2018 | -39.4% | |
| Oct 2018 | -10.9% | |
| Sep 2018 | -10.5% | |
| Aug 2018 | -6.9% | |
| Jul 2018 | -8.1% | |
| Jun 2018 | +5.3% | |
| May 2018 | +134.7% | |
| Apr 2018 | -3.1% | |
| Mar 2018 | -7.3% | |
| Feb 2018 | -15.1% | |
| Jan 2018 | +61.7% | |
| Dec 2017 | +82.3% | |
| Nov 2017 | +0.7% | |
| Oct 2017 | +11.1% | |
| Sep 2017 | +163.3% | |
| Aug 2017 | +10.2% | |
| Jul 2017 | -4.7% | |
| Jun 2017 | +6.8% | |
| May 2017 | -7.8% | |
| Apr 2017 | +7.1% | |
| Mar 2017 | -1.3% | |
| Feb 2017 | +2.1% | |
| Jan 2017 | +2.6% | |
| Dec 2016 | -6.9% |
Monthly total return (since Dec 2021)#
Madrigal Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 2007, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
November 2026 so far: -1.94% — 14th of 20 Novembers since 2007 at the last close; the average November returned +6.4%.
| Month | −315%0+315% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +1.4% | -0.7% | 47% | +61.7% 2018 | -32.1% 2022 | |
| Feb | -0.7% | +2.0% | 63% | +61.3% 2022 | -84.5% 2009 | |
| Mar | -0.9% | -4.0% | 35% | +57.4% 2009 | -30.3% 2014 | |
| Apr | +7.5% | +0.9% | 55% | +66.7% 2016 | -28.7% 2022 | |
| May | +4.6% | -5.0% | 35% | +134.7% 2018 | -28.0% 2013 | |
| Jun | -4.7% | -1.3% | 45% | +18.6% 2024 | -44.0% 2009 | |
| Jul | +0.4% | -4.8% | 30% | +34.5% 2013 | -17.6% 2016 | |
| Aug | +2.9% | -2.0% | 50% | +53.9% 2016 | -24.7% 2007 | |
| Sep | +6.5% | -5.1% | 45% | +163.3% 2017 | -24.8% 2014 | |
| Oct | -1.6% | -2.1% | 45% | +30.1% 2016 | -61.5% 2015 | |
| Nov | +6.4% | +6.4% | 63% | +54.7% 2023 | -39.4% 2018 | |
| Dec | +23.1% | +2.5% | 53% | +314.0% 2022 | -18.6% 2015 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from MDGL's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Madrigal Pharmaceuticals Inc.'s average monthly return?
- Madrigal Pharmaceuticals Inc. has averaged about 3.65% per month (dividends reinvested), positive in roughly 47% of months. The best month was Dec 2022 (+314.0%) and the worst was Feb 2009 (-84.5%).
